SAFES Guidelines

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Safe and pragmatic use of SGLT2 inhibitors in type 2 diabetes mellitus: SAFES consensus statement

Executive Summary: Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)

JPMA Gestational Diabetes Guidelines